MADRIGAL PHARMACEUTICALS, INC. (MDGL) Stock Research
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Latest price: 517.04 · Sector: Healthcare
Recent Insider Transactions
| Insider | Type | Date | Value |
|---|---|---|---|
| Sibold William John | sell | 2026-09-11 | 414616.16 |
| Sibold William John | sell | 2026-09-11 | 837252.94 |
| Sibold William John | sell | 2026-09-11 | 371382.38 |
| Sibold William John | sell | 2026-09-11 | 86018.8 |
| Sibold William John | sell | 2026-09-11 | 199324.37 |
| Sibold William John | sell | 2026-09-11 | 652209.05 |
| Sibold William John | sell | 2026-09-11 | 56610.68 |
| Sibold William John | sell | 2026-09-11 | 31985.48 |
| Sibold William John | sell | 2026-09-11 | 116835.68 |
| Sibold William John | sell | 2026-09-11 | 65565.2 |